Publikationen, an denen er mitarbeitet Sonia Alcalá Sánchez (3)

2021

  1. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

  2. Inhibition of mitochondrial dynamics preferentially targets pancreatic cancer cells with enhanced tumorigenic and invasive potential

    Cancers, Vol. 13, Núm. 4, pp. 1-21

2020

  1. Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells

    Nature Communications, Vol. 11, Núm. 1